简体
简体中文
繁體中文

Market Vectors Colombia ETF COLX

等待开盘 08-02 09:30:00 美东时间

0.00

0.000

NaN.00%

华盛通华盛通
立即下载
  • 最 高--
  • 今 开--
  • 成交量 0股
  • 最 低 --
  • 昨 收 0.00
  • 总市值 0
  • 52周最高 0.00
  • 市盈率 --
  • 换手率 NaN.00%
  • 52周最低 0.00
  • 委 比 0.00%
  • 总股本 --
  • 历史最高 0.00
  • 量 比 0
  • 振 幅 NaN.00%
  • 历史最低 0.00
  • 每 手 1
  • 风险率

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

    Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced it will report second quarter 2025 financial results before the market opens on Thursday, August 7, 2025. A live conference call and webcast will be held at 8:00 a.m. ET. Investors can join via phone at (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference "Collegium Pharmaceutical Q2 2025 Earnings Call." The webcast will be available on the Company’s website at www.collegium...

    07-24 12:00

  • Collegium Announces $150 Million Share Repurchase Program

    Collegium Pharmaceutical, Inc. announced a new $150 million stock repurchase program through December 31, 2026, replacing a previous program that expired with $65 million remaining. The company has returned $222 million to shareholders since 2021 and currently has 32.1 million shares outstanding.

    07-07 12:00